Eisai Delivers New Data and Highlights Continued Progress of Oncology Portfolio and Pipeline at ASCO 2023
- Tuesday, May 23, 2023, 7:13
- PR Newswire
- Add a comment
Final Pre-Specified Overall Survival Analysis from the Pivotal Phase 3 CLEAR Trial in Patients with Advanced Renal Cell Carcinoma Will Be Featured in an Oral Presentation NUTLEY, N.J., May 23, 2023 /PRNewswire/ — Eisai announced today the presentation of research across various types of…
About the Author
admin has written 21137 stories on this site.